Earnings Per Share, Diluted in USD/shares of ZEVRA THERAPEUTICS, INC. from Q1 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Zevra Therapeutics, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q1 2015 to Q3 2025.
  • Zevra Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2025 was -0.01 USD/shares, a 98.6% increase year-over-year.
  • Zevra Therapeutics, Inc. annual Earnings Per Share, Diluted for 2021 was -2.11 USD/shares, a 34.3% increase from 2020.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)

ZEVRA THERAPEUTICS, INC. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 +$0.68 +98.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $1.21 +$1.69 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q3 2024 -$1 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q4 2021 -$2 $0.84 +$1.66 Oct 1, 2021 Dec 31, 2021 10-K 2022-03-31
Q3 2021 -$3 $0 +$0.62 +91.2% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$4 $0 -$1 -290% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-13
Q1 2021 -$3 -$2 -$1 -29.7% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-14
Q4 2020 -$3 -$1 Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$1 -$1 -1233% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0.21 +$0.54 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$2 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $0.06 +$1.00 Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $0 +$0.58 +63.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q3 2018 -$1 $0 -38.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1 $0 -107% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q4 2017 -$2 -$1 $0 -5.88% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-30
Q3 2017 -$2 -$1 +$0.24 +26.1% Jul 1, 2017 Sep 30, 2017 10-K 2018-03-30
Q2 2017 -$3 $0 +$0.14 +24.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$3 -$1 -$1 -455% Jan 1, 2017 Mar 31, 2017 10-K 2018-03-30
Q4 2016 -$2 -$1 $0 -6.25% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$2 -$1 $0 -35.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-30
Q2 2016 -$2 -$1 +$1.87 +76.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-30
Q1 2016 -$3 $0 +$2.30 +92% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-30
Q4 2015 -$6 -$1 Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$1 Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$2 Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$3 Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10

ZEVRA THERAPEUTICS, INC. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$2 +$1.10 +34.3% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 -$3 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.